Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Amphotericin B Induction for Histoplasmosis in AIDS
NCT04059770Phase 2Completed
- Start
- Feb 2020
- Primary completion
- Dec 2021
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal amphotericin b in Disseminated Histoplasmosis (DH). Started Feb 2020; status: completed.
02
Drugs
liposomal amphotericin b
03
Conditions
Disseminated Histoplasmosis (DH)
Beyond the preview
Go deeper on NCT04059770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059770.